Invasive aspergillosis in children and adolescents

Andreas H Groll1, Dominik Schrey, Athanasios Tragiannidis

  • 1Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany. grollan@ukmuenster.de

Insights

Invasive aspergillosis in immunocompromised children presents unique challenges. This review covers diagnosis, treatment, and prevention strategies specific to pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Mycology
  • Immunocompromised Host

Background:

  • Invasive aspergillosis is a significant cause of illness and death in immunocompromised children.
  • Effective disease control requires a multi-faceted approach including prevention, early diagnosis, and treatment.
  • Pediatric invasive aspergillosis differs from adult forms in presentation, epidemiology, diagnostics, and antifungal pharmacokinetics.

Purpose of the Study:

  • To review the clinical presentation and epidemiology of invasive aspergillosis in children and adolescents.
  • To discuss the utility of current diagnostic tools and strategies for this population.
  • To explore treatment and prevention options tailored for pediatric patients.

Main Methods:

  • Literature review focusing on invasive aspergillosis in pediatric populations.
  • Analysis of clinical presentation and epidemiological data.
  • Evaluation of diagnostic tools, treatment modalities, and preventive measures.

Main Results:

  • Invasive aspergillosis in children and adolescents has distinct clinical and epidemiological features compared to adults.
  • Newer diagnostic tools and antifungal pharmacokinetics offer unique considerations for pediatric care.
  • A comprehensive strategy is essential for managing this infection in immunocompromised youth.

Conclusions:

  • Understanding the unique aspects of invasive aspergillosis in children is crucial for effective management.
  • Optimizing diagnostic and therapeutic approaches is vital for improving outcomes.
  • Further research into pediatric-specific strategies for prevention and treatment is warranted.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...